Expression of the Epstein‐Barr virus (EBV) encoded nuclear antigens (EBNA 1 to 6) and
membrane‐associated protein (LMP) was investigated by immunoblotting in 83 …

The BamHI fragment containing the Epstein-Barr virus (EBV) LMP1 gene was cloned from a
genomic library of the nude mouse-propagated Chinese nasopharyngeal carcinoma CAO. …

BACKGROUND Serologic measurement of antibodies to Epstein–Barr virus (EBV) immunoglobulin
A/viral capsid antigen (IgA/VCA) and early antigen (IgA/EA) has been used widely to …

Two isolates of the EBV-LMP1 gene were compared for their ability to induce phenotypic
changes in a non-tumorigenic human keratinocyte line, Rhek-1, immortalized with an …

The role of microRNA-155 (miR-155) has been associated with oncogenesis of several
human tumors. However the expression pattern of miR-155 has not been investigated in …

Background: The plasma Epstein-Barr virus DNA (EBV-DNA) level has been found to be an
indicator for staging and prognosis of nasopharyngeal carcinoma (NPC). Materials and …

Using reverse transcription of whole cellular RNA and nested PCR, we have performed
experiments mixing different proportions of Epstein-Barr virus (EBV)-carrying and EBV-negative …

All low differentiated or anaplastic forms of nasopharyngeal carcinoma (NPC) carry multiple
copies of EBV-DNA and express EBNA1. The major membrane protein, LMP1, is only …

The major obstacles of anti‐PD therapy in metastatic tumors are limited drug delivery in
primary tumors and metastatic foci, and the lack of tumor‐infiltrating lymphocytes (TILs). Here, …

Background Epstein‐Barr virus (EBV) commonly infects the general population and has been
associated with nasopharyngeal carcinoma (NPC), which has a high incidence in certain …